Listening to Prozac

Last updated
Cover of Listening to Prozac Listening-to-Prozac.jpg
Cover of Listening to Prozac

Listening to Prozac: A Psychiatrist Explores Antidepressant Drugs and the Remaking of the Self is a book written by psychiatrist Peter D. Kramer. Written in 1993, the book discusses how the advance of the anti-depressant drug Prozac might change the way we see personality, the relationship between neurology and personality.

Contents

Kramer coined the term "cosmetic pharmacology", and in this book he discusses the philosophical, ethical and social consequences of using psychopharmacology to change one's personality. He asks if it is ethically defensible to treat a healthy individual to, for instance, help him climb a career, or on the other hand, if it is ethically defensible to deny him that possibility. Listening to Prozac spent 4 months on the New York Times best seller's list [1] and its influence prompted critics to write books with sound alike names such as Peter Breggin's Talking Back to Prozac . [2]

The Fort Lauderdale Sun Sentinel described the book as "one of the most provocative popular science books published in 1993", stating that "Kramer is in full command of the array of knowledge - from cellular biology to animal studies to literature - that he draws upon to put the impact of antidepressants into perspective. In his hands, ancient ideas suddenly seem vital again, cast in a new and disquieting light by Prozac." [1]

In a review in the New York Review of Books, Sherwin B. Nuland said that Kramer has "played fast and loose with the most basic principles by which physicians evaluate clinical experience and propose new ways of explaining or treating illness. Those principles require (1) meticulous and personally made observations of an illness or maladaptive state; (2) even-handed review of all pertinent publications that bear on the problem; (3) scrupulous attention to every fragment of clinical evidence, whether or not it supports the observer’s evolving hypothesis; and (4) a commitment not to speculate beyond what is justified by the accumulated data and its supportable implications." [3] Nuland said that Kramer has used his preliminary observations to hype unjustified assertions in trade books and on TV shows, orchestrated by professional publicists. Kramer responded to this review, stating that Nuland " goes on tediously establishing his bona fides as an old-style doctor (trained by the ostensibly witty Dr. Bean, familiar with the story of serotonin, etc., etc.)—and then fails to illustrate his attack with a single specific." [4]

The Kirkus Reviews described Listening to Prozac as "thoughtful questioning is supported throughout by case histories and meaty reports on recent research.... A wise and unflinching examination of the ramifications for society--and for the individual--when the capsule replaces the couch." [5]

Daniel X. Freedman, former president of the American Psychiatric Association, wrote that Listening to Prozac “does not provide reliable directions for those in troubled quest of self or those seeking a clear introduction to the brain sciences and pharmacology.” [6]

Publishing Information

See also

Related Research Articles

<span class="mw-page-title-main">Antidepressant</span> Class of medication used to treat depression and other conditions

Antidepressants are a class of medications used to treat major depressive disorder, anxiety disorders, chronic pain, and addiction.

<span class="mw-page-title-main">Tricyclic antidepressant</span> Class of medications

Tricyclic antidepressants (TCAs) are a class of medications that are used primarily as antidepressants, which is important for the management of depression. They are second-line drugs next to SSRIs. TCAs were discovered in the early 1950s and were marketed later in the decade. They are named after their chemical structure, which contains three rings of atoms. Tetracyclic antidepressants (TeCAs), which contain four rings of atoms, are a closely related group of antidepressant compounds.

<span class="mw-page-title-main">Psychiatric medication</span> Medication used to treat mental disorders

A psychiatric or psychotropic medication is a psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system. Thus, these medications are used to treat mental illnesses. These medications are typically made of synthetic chemical compounds and are usually prescribed in psychiatric settings, potentially involuntarily during commitment. Since the mid-20th century, such medications have been leading treatments for a broad range of mental disorders and have decreased the need for long-term hospitalization, thereby lowering the cost of mental health care. The recidivism or rehospitalization of the mentally ill is at a high rate in many countries, and the reasons for the relapses are under research.

<i>Prozac Nation</i> Memoir by Elizabeth Wurtzel

Prozac Nation is a memoir by American writer Elizabeth Wurtzel published in 1994. The book describes the author's experiences with atypical depression, her own character failings and how she managed to live through particularly difficult periods while completing college and working as a writer. Prozac is a trade name for the antidepressant fluoxetine. Wurtzel originally titled the book I Hate Myself and I Want To Die but her editor convinced her otherwise. It ultimately carried the subtitle Young and Depressed in America: A Memoir.

<span class="mw-page-title-main">David Healy (psychiatrist)</span> Irish-born pharmacologist

David HealyFRCPsych, a professor of psychiatry at Bangor University in the United Kingdom, is a psychiatrist, psychopharmacologist, scientist and author. His main areas of research are the contribution of antidepressants to suicide, conflict of interest between pharmaceutical companies and academic medicine, and the history of pharmacology. Healy has written more than 150 peer-reviewed articles, 200 other articles, and 20 books, including The Antidepressant Era, The Creation of Psychopharmacology, The Psychopharmacologists Volumes 1–3, Let Them Eat Prozac and Mania: A Short History of Bipolar Disorder.

Peter Roger Breggin is an American psychiatrist and critic of shock treatment and psychiatric medication and COVID-19 response. In his books, he advocates replacing psychiatry's use of drugs and electroconvulsive therapy with psychotherapy, education, empathy, love, and broader human services.

Biological psychiatry or biopsychiatry is an approach to psychiatry that aims to understand mental disorder in terms of the biological function of the nervous system. It is interdisciplinary in its approach and draws on sciences such as neuroscience, psychopharmacology, biochemistry, genetics, epigenetics and physiology to investigate the biological bases of behavior and psychopathology. Biopsychiatry is the branch of medicine which deals with the study of the biological function of the nervous system in mental disorders.

Peter D. Kramer is an American psychiatrist and faculty member of Brown Medical School specializing in the area of clinical depression.

<span class="mw-page-title-main">Sherwin B. Nuland</span> American surgeon and writer

Sherwin Bernard Nuland was an American surgeon and writer who taught bioethics, history of medicine, and medicine at the Yale School of Medicine, and occasionally bioethics and history of medicine at Yale College. His 1994 book How We Die: Reflections on Life's Final Chapter was a New York Times Best Seller and won the National Book Award for Nonfiction, as well as being a finalist for the Pulitzer Prize.

<span class="mw-page-title-main">Fluoxetine</span> SSRI Antidepressant

Fluoxetine, sold under the brand name Prozac, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), bulimia nervosa, panic disorder, and premenstrual dysphoric disorder. It is also approved for treatment of major depressive disorder in adolescents and children 8 years of age and over. It has also been used to treat premature ejaculation. Fluoxetine is taken by mouth.

Cosmetic psychopharmacology, a term coined in 1990 by the psychiatrist Peter D. Kramer and popularized in his 1993 book Listening to Prozac, refers to the use of drugs to move persons from a normal psychological state to another normal state that is more desired or better socially rewarded — e.g., from melancholy towards assertiveness and confidence or from slower to quicker cognition.

<span class="mw-page-title-main">Femoxetine</span> Chemical compound

Femoxetine is a drug related to paroxetine that was being developed as an antidepressant by Danish pharmaceutical company Ferrosan in 1975 before acquisition of the company by Novo Nordisk. It acts as a selective serotonin reuptake inhibitor (SSRI). Development was halted to focus attention on paroxetine instead, as femoxetine could not be administered as a daily pill.

Challenge–dechallenge–rechallenge (CDR) is a medical testing protocol in which a medicine or drug is administered, withdrawn, then re-administered, while being monitored for adverse effects at each stage. The protocol is used when statistical testing is inappropriate due to an idiosyncratic reaction by a specific individual, or a lack of sufficient test subjects and unit of analysis is the individual. During the dechallenge (withdrawal) phase, the medication is allowed to wash out of the system in order to determine what effect the medication is having on an individual.

The Critical Psychiatry Network (CPN) is a psychiatric organization based in the United Kingdom. It was created by a group of British psychiatrists who met in Bradford, England in January 1999 in response to proposals by the British government to amend the Mental Health Act 1983. They expressed concern about the implications of the proposed changes for human rights and the civil liberties of people with mental health illness. Most people associated with the group are practicing consultant psychiatrists in the United Kingdom's National Health Service (NHS), among them Dr Joanna Moncrieff. A number of non-consultant grade and trainee psychiatrists are also involved in the network.

<span class="mw-page-title-main">Irving Kirsch</span>

Irving Kirsch is an American psychologist and academic. He is the Associate Director of the Program in Placebo Studies and a lecturer in medicine at the Harvard Medical School and Beth Israel Deaconess Medical Center. He is also professor emeritus of psychology at the Universities of Hull and Plymouth in the United Kingdom, and the University of Connecticut in the United States. Kirsch is a leading researcher within the field of placebo studies who is noted for his work on placebo effects, antidepressants, expectancy, and hypnosis. He is the originator of response expectancy theory, and his analyses of clinical trials of antidepressants have influenced official treatment guidelines in the United Kingdom. He is the author of the 2009 book The Emperor's New Drugs, which argued most antidepressant medication is effective primarily due to placebo effects.

Joshua Kennedy Lyon is an American journalist and author. He is the author of Pill Head: The Secret Life of a Painkiller Addict, published by Hyperion on July 7, 2009. Pill Head is part memoir, part investigative journalism and chronicles prescription painkiller abuse in America. He currently resides in Brooklyn, New York.

Pharmacological Calvinism is a term of disapproval purporting to describe the disapproving or condemning attitude of some Americans to the use of psychiatric medication. The term describes a perceived general distrust of drug use for purposes of restoring or attaining pleasure or happiness; that the only legitimate use of drugs is for the purpose of curing or treating illness and disease. The term was first used in 1972 by psychiatrist Gerald L. Klerman (1929–1992).

<i>The Emperors New Drugs</i>

The Emperor's New Drugs – Exploding the Antidepressant Myth is a 2009 book by Irving Kirsch, arguing that the chemical imbalance theory of depression is wrong and that antidepressants have little or no direct effect on depression but, because of their common or serious side-effects, they are powerful active placebos.

Joanna Moncrieff is a British psychiatrist and academic. She is Professor of Critical and Social Psychiatry at University College London and a leading figure in the Critical Psychiatry Network. She is a prominent critic of the modern 'psychopharmacological' model of mental disorder and drug treatment, and the role of the pharmaceutical industry. She has written papers, books and blogs on the use and over-use of drug treatment for mental health problems, the mechanism of action of psychiatric drugs, their subjective and psychoactive effects, the history of drug treatment, and the evidence for its benefits and harms. She also writes on the history and politics of psychiatry more generally. Her best known books are The Myth of the Chemical Cure and The Bitterest Pills.

<span class="mw-page-title-main">Wallace B. Mendelson</span>

Wallace B. Mendelson is an American psychiatrist and author, working primarily in the fields of sleep research and psychopharmacology. He most recently worked at the University of Chicago as a professor of psychiatry and clinical pharmacology and the director of the school's Sleep Research Laboratory. He is the author of thirteen books and numerous papers in the fields of sleep science and pharmacology.

References

  1. 1 2 "It's Better Living - Sun Sentinel".
  2. Breggin, P. R. and Breggin, G. R. (1994). Talking Back To Prozac: What Doctors Aren't Telling You About Today's Most Controversial Drug. New York: St. Martin's Press.
  3. The Pill of Pills, by Sherwin B. Nuland, New York Review of Books, June 9, 1994. Review of Listening to Prozac, by Peter D. Kramer.
  4. Nuland, Sherwin B.; Kramer, Peter D. "'Listening to Prozac' by Peter D. Kramer | The New York Review of Books".{{cite magazine}}: Cite magazine requires |magazine= (help)
  5. "LISTENING TO PROZAC by Peter D. Kramer | Kirkus".
  6. New York Times Book Review, August 8, 1993